Hrt Financial LP Care Dx, Inc. Transaction History

Hrt Financial LP

$18.1 Billion
Q3 2024

A detailed history of Hrt Financial LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 40,198 shares of CDNA stock, worth $938,221. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,198

Previous 65,299 38.44%

Holding current value

$938,221

Previous $1.01 Million 23.67%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$14.41 - $33.99 $361,705 - $853,182	-25,101 Reduced 38.44%	40,198 $1.25 Million
Q2 2024 Aug 12, 2024	BUY	$7.56 - $16.15 $493,660 - $1.05 Million	65,299 New	65,299 $1.01 Million
Q4 2023 Feb 09, 2024	SELL	$4.9 - $12.86 $66,037 - $173,314	-13,477 Reduced 28.04%	34,589 $415,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $11.26 $672,588 - $1.08 Million	-96,084 Reduced 66.66%	48,066 $336,000
Q2 2023 Aug 11, 2023	BUY	$7.61 - $9.46 $1.1 Million - $1.36 Million	144,150 New	144,150 $1.23 Million
Q2 2022 Aug 12, 2022	SELL	$20.49 - $39.72 $494,382 - $958,364	-24,128 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $318,377 - $526,300	11,294 Added 88.0%	24,128 $892,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $173,040 - $309,120	4,200 Added 48.64%	12,834 $583,000
Q3 2021 Nov 15, 2021	SELL	$59.15 - $91.99 $2.37 Million - $3.69 Million	-40,112 Reduced 82.29%	8,634 $547,000
Q2 2021 Aug 16, 2021	BUY	$63.02 - $95.11 $3.07 Million - $4.64 Million	48,746 New	48,746 $4.46 Million
Q4 2019 Feb 14, 2020	SELL	$19.24 - $28.41 $400,769 - $591,780	-20,830 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $417,224 - $834,866	20,830 New	20,830 $470,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

51.1M

Call Options Held

97.3K

Put Options Held

43.3K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.25B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Account